Sigilon Therapeutics, Inc.

United States of America


 
Total IP 90
Total IP Rank # 14,608
IP Activity Score 2.8/5.0    85
IP Activity Rank # 8,200
Dominant Nice Class Chemical and biological material...

Patents

Trademarks

23 6
17 5
34 5
0
 
Last Patent 2025 - Compositions for cell-based ther...
First Patent 2017 - Compounds, devices, and uses the...
Last Trademark 2020 - SLTX
First Trademark 2015 - SIGILON

Industry (Nice Classification)

Latest Inventions, Goods, Services

2023 Invention Compounds, devices, and uses thereof. The present invention provides compounds, e.g., compounds ...
Invention Engineered cells and implantable elements for treatment of disease. Described herein are engineer...
Invention Hydrogel capsules comprising covalently photocrosslinked polysaccharides and islet cells. Describ...
Invention Covalently crosslinked polysaccharides and methods of use thereof. Described herein are hydrogel ...
Invention Covalently photocrosslinked polysaccharides and methods of use thereof. Described herein are poly...
Invention Modified polysaccharide polymers and related compositions and methods thereof. Described herein a...
Invention Compositions, devices and methods for treating cns disorders. Described herein are BBB-transporti...
Invention Therapies for mucopolysaccharidosis type 6. Described herein are ARSB fusion proteins, polynucleo...
2022 Invention Compositions for cell-based therapies and related methods. Described herein are hydrogel capsule...
Invention Compositions for cell-based therapies and related methods. Described herein are hydrogel capsule ...
Invention Genetically modified human cell lines and uses thereof. Described herein are genetically modifie...
Invention Genetically modified human cell lines and uses thereof. Described herein are genetically modified...
Invention Compositions, devices and methods for treating mps vi disease. Described herein are mammalian ce...
Invention Compositions, devices and methods for treating mps vi disease. Described herein are mammalian cel...
Invention Compositions, devices and methods for inducing antigen-specific immune tolerance. Described here...
Invention Compositions, devices and methods for treating immune-mediated inflammatory diseases. Described ...
Invention Compositions, devices and methods for treating immune-mediated inflammatory diseases. Described h...
Invention Compositions, devices and methods for inducing antigen-specific immune tolerance. Described herei...
Invention Biocompatible devices for cell-based therapies and related methods. Described herein are implanta...
2021 Invention Heteroaryl and heterocyclyl compounds. Described herein are compounds of Formulas (I), (II), and...
Invention Heteroaryl and heterocyclyl compounds. Described herein are compounds of Formulas (I), (II), and ...
Invention Genetically modified cell lines expressing an exogenous substance and uses thereof. Described he...
Invention Genetically modified cell lines expressing an exogenous substance and uses thereof. Described her...
Invention Compositions, devices and methods for inducing immune responses to infectious agents. Described ...
Invention Compositions, devices and methods for inducing immune responses to infectious agents. Described h...
2020 Invention Compounds, polymers, devices, and uses thereof. Described herein are compounds of Formula (I), p...
Invention Compounds, polymers, devices, and uses thereof. Described herein are compounds of Formula (I), po...
Invention Apparatuses and methods for formation of particles. Described herein are apparatuses and methods...
Invention Apparatuses and methods for formation of particles. Described herein are apparatuses and methods ...
Invention Monoclonal cell lines expressing an exogenous substance and uses thereof. Described herein are g...
Invention Monoclonal cell lines expressing an exogenous substance and uses thereof. Described herein are ge...
Invention Methods of evaluating small molecule-modified polymers in compositions. Described herein are met...
Invention Methods of evaluating polypeptide-modified polymers in compositions. Described herein are method...
G/S Chemical, pharmaceutical, biopharmaceutical and biomedical agents for medical use, namely, pharma...
G/S Chemical, pharmaceutical, biopharmaceutical and biomedical agents for medical use, namely, pharm...
Invention Compositions, devices, and methods for factor vii therapy. Described herein are RPE cells engine...
Invention Compositions, devices, and methods for treating fabry disease. Described herein are RPE cells en...
2019 Invention Implantable devices for cell therapy and related methods. Described herein are implantable devic...
G/S Chemical agents for coating of medical devices and medical materials; reagents for research purp...
G/S Chemical agents for coating of medical devices and medical materials for use in the research, dis...
Invention Methods, compositions, and implantable elements comprising stem cells. Described herein are cell...
2018 G/S Chemical agents for coating of medical devices and medical materials; reagents for research purpo...
G/S Chemical agents for coating of medical devices, medical materials, and for encapsulating pharmace...
G/S Chemical agents for scientific and research use, namely, small molecules for purposes of preventi...
G/S Chemical agents for scientific and research use, namely, small molecules in the nature of chemica...
G/S Chemical agents for scientific and research use, namely, small molecules in the nature of chemic...
2017 G/S Chemical agents for coating of medical devices, medical materials, and for encapsulating pharmac...
G/S Chemical agents for scientific and research use, namely, small molecules; chemical agents for co...
2015 G/S Agents for scientific and research use, namely, small molecules; chemical agents for coating of m...